KLSE:HARTA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Hartalega Holdings Berhad

Executive Summary

Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, rest of Asia, Europe, Australia, North America, South America, the Middle East, Russia, and internationally. More Details


Snowflake Analysis

Outstanding track record with excellent balance sheet.


Similar Companies

Share Price & News

How has Hartalega Holdings Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HARTA is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: HARTA's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

4.0%

HARTA

-2.2%

MY Medical Equipment

-0.4%

MY Market


1 Year Return

178.2%

HARTA

272.0%

MY Medical Equipment

1.4%

MY Market

Return vs Industry: HARTA underperformed the MY Medical Equipment industry which returned 272% over the past year.

Return vs Market: HARTA exceeded the MY Market which returned 1.4% over the past year.


Shareholder returns

HARTAIndustryMarket
7 Day4.0%-2.2%-0.4%
30 Day-19.8%-19.9%6.1%
90 Day-11.3%-20.3%2.4%
1 Year180.8%178.2%277.6%272.0%4.6%1.4%
3 Year218.7%206.7%361.2%341.1%0.08%-11.4%
5 Year477.3%438.0%547.5%495.8%9.8%-8.4%

Long-Term Price Volatility Vs. Market

How volatile is Hartalega Holdings Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Hartalega Holdings Berhad undervalued compared to its fair value and its price relative to the market?

49.77x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: HARTA (MYR14.66) is trading above our estimate of fair value (MYR14.54)

Significantly Below Fair Value: HARTA is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HARTA is poor value based on its PE Ratio (49.8x) compared to the MY Medical Equipment industry average (27.9x).

PE vs Market: HARTA is poor value based on its PE Ratio (49.8x) compared to the MY market (19.6x).


Price to Earnings Growth Ratio

PEG Ratio: HARTA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: HARTA is overvalued based on its PB Ratio (14.8x) compared to the MY Medical Equipment industry average (8x).


Next Steps

Future Growth

How is Hartalega Holdings Berhad forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

-5.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HARTA's earnings are forecast to decline over the next 3 years (-5.5% per year).

Earnings vs Market: HARTA's earnings are forecast to decline over the next 3 years (-5.5% per year).

High Growth Earnings: HARTA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: HARTA's revenue (2.3% per year) is forecast to grow slower than the MY market (7.8% per year).

High Growth Revenue: HARTA's revenue (2.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HARTA's Return on Equity is forecast to be very high in 3 years time (60.3%).


Next Steps

Past Performance

How has Hartalega Holdings Berhad performed over the past 5 years?

20.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HARTA has high quality earnings.

Growing Profit Margin: HARTA's current net profit margins (26%) are higher than last year (14.8%).


Past Earnings Growth Analysis

Earnings Trend: HARTA's earnings have grown significantly by 20.9% per year over the past 5 years.

Accelerating Growth: HARTA's earnings growth over the past year (145.2%) exceeds its 5-year average (20.9% per year).

Earnings vs Industry: HARTA earnings growth over the past year (145.2%) exceeded the Medical Equipment industry 19.9%.


Return on Equity

High ROE: HARTA's Return on Equity (29.7%) is considered high.


Next Steps

Financial Health

How is Hartalega Holdings Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: HARTA's short term assets (MYR2.6B) exceed its short term liabilities (MYR990.9M).

Long Term Liabilities: HARTA's short term assets (MYR2.6B) exceed its long term liabilities (MYR494.1M).


Debt to Equity History and Analysis

Debt Level: HARTA's debt to equity ratio (11.4%) is considered satisfactory.

Reducing Debt: HARTA's debt to equity ratio has increased from 4.5% to 11.4% over the past 5 years.

Debt Coverage: HARTA's debt is well covered by operating cash flow (421.7%).

Interest Coverage: HARTA's interest payments on its debt are well covered by EBIT (157.1x coverage).


Balance Sheet


Next Steps

Dividend

What is Hartalega Holdings Berhad current dividend yield, its reliability and sustainability?

0.53%

Current Dividend Yield


Upcoming Dividend Payment


Dividend Yield vs Market

Notable Dividend: HARTA's dividend (0.53%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.51%).

High Dividend: HARTA's dividend (0.53%) is low compared to the top 25% of dividend payers in the MY market (4.56%).


Stability and Growth of Payments

Stable Dividend: HARTA is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.

Growing Dividend: HARTA is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: HARTA is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HARTA's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.0yrs

Average management tenure


CEO

Mun Kuan (44 yo)

8yrs

Tenure

RM120,000

Compensation

Mr. Mun Leong Kuan has been a Chief Executive Officer of Hartalega Holdings Berhad since May 18, 2020 and has been its Managing Director since November 16, 2012. Mr. Kuan served as Deputy Managing Director...


Leadership Team

NamePositionTenureCompensationOwnership
Kam Kuan
Executive Chairman13.5yrsRM120.00k50.02%
MYR 24.7b
Mun Kuan
CEO & Non-Independent Executive Director8yrsRM120.00k0.46%
MYR 229.1m
Mun Kuan
Sales & Marketing Director12.33yrsRM120.00k0.32%
MYR 156.5m
Kean Loh
Chief Financial Officer0.75yrno datano data
Eu Kuan
Chief Operating Officer0.50yrno data0.71%
MYR 348.0m
Wah Leang
General Manager of Information Technology5.33yrsno datano data
Jayden Liew
Manager of Investor Relationsno datano datano data
Vin Kuan
Chief Human Resource Officer11.25yrsno datano data
Teck Tan
General Manager of Financeno datano datano data
Fook Lai
Head Scientist of Innovation1.92yrsno datano data
Maw Wong
Company Secretary12.25yrsno datano data
Youn Wong
Company Secretary8.25yrsno datano data

8.0yrs

Average Tenure

45yo

Average Age

Experienced Management: HARTA's management team is seasoned and experienced (8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kam Kuan
Executive Chairman13.5yrsRM120.00k50.02%
MYR 24.7b
Mun Kuan
CEO & Non-Independent Executive Director8yrsRM120.00k0.46%
MYR 229.1m
Mun Kuan
Sales & Marketing Director12.33yrsRM120.00k0.32%
MYR 156.5m
Guan Cheong Tan
Independent Non Executive Director8.92yrsRM127.00k0.011%
MYR 5.5m
Razman Bin Abu Zarim
Independent & Non Executive Director5.67yrsRM127.00kno data
Rebecca Sta Maria
Senior Independent Non-Executive Director2.5yrsRM127.00kno data
Nurmala Binti Abd Rahim
Independent Non-Executive Director4.25yrsRM127.00kno data
Took Loo
Independent Non Executive Director1yrRM50.75k0.00015%
MYR 74.0k

7.3yrs

Average Tenure

64.5yo

Average Age

Experienced Board: HARTA's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Hartalega Holdings Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Hartalega Holdings Berhad
  • Ticker: HARTA
  • Exchange: KLSE
  • Founded: 1988
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: RM49.317b
  • Shares outstanding: 3.43b
  • Website: https://www.hartalega.com.my

Number of Employees


Location

  • Hartalega Holdings Berhad
  • C-G-9, Jalan Dataran SD1
  • Dataran SD, PJU 9
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 52200
  • Malaysia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HARTAKLSE (Bursa Malaysia)YesOrdinary SharesMYMYRApr 2008

Biography

Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, rest of Asia, Europe, Australia, North America, South Am...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/26 11:07
End of Day Share Price2020/11/26 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.